+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Next Generation Sequencing CLIA Laboratory Services Market Research Report by Technology, Certificate Types, Application, End-users, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

  • PDF Icon

    Report

  • 121 Pages
  • January 2023
  • Region: United States
  • 360iResearch™
  • ID: 5722767
The United States Next Generation Sequencing CLIA Laboratory Services Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Next Generation Sequencing CLIA Laboratory Services Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Next Generation Sequencing CLIA Laboratory Services Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Next Generation Sequencing CLIA Laboratory Services Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Next Generation Sequencing CLIA Laboratory Services Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the United States Next Generation Sequencing CLIA Laboratory Services Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Next Generation Sequencing CLIA Laboratory Services Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Technology, the market is studied across Cell Free DNA Sequencing, Metagenomic Sequencing, NGS Gene Panel Sequencing, Targeted Sequencing & Re-sequencing, Whole Exome Sequencing, and Whole Genome Sequencing.
  • Based on Certificate Types, the market is studied across Certificate for Provider-Performed Microscopy Procedures, Certificate of Accreditation, Certificate of Compliance, Certificate of Registration, and Certificate of Waiver.
  • Based on Application, the market is studied across Biomarker Discovery, Diagnostics, Drug Discovery, and Precision Medicine.
  • Based on End-users, the market is studied across Diagnostic Centers and Hospitals.
  • Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Next Generation Sequencing CLIA Laboratory Services Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Next Generation Sequencing CLIA Laboratory Services Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Next Generation Sequencing CLIA Laboratory Services Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Next Generation Sequencing CLIA Laboratory Services Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Next Generation Sequencing CLIA Laboratory Services Market, including Agilent Technologies, Inc., Azenta Life Sciences, Beijing Genomics Co. Ltd., Bio-Rad Laboratories, Inc., BioMerieux S.A., Charles River Laboratories, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Illumina, Inc., Macrogen, Inc., NanoString Technologies, Inc., Perkin Elmer, Inc., PierianDx, Inc., Pillar Biosciences, Inc., Qiagen N.V., Saphetor SA, Takara Bio Inc., and Thermo Fisher Scientific, Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Next Generation Sequencing CLIA Laboratory Services Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Next Generation Sequencing CLIA Laboratory Services Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Next Generation Sequencing CLIA Laboratory Services Market?
4. What is the competitive strategic window for opportunities in the United States Next Generation Sequencing CLIA Laboratory Services Market?
5. What are the technology trends and regulatory frameworks in the United States Next Generation Sequencing CLIA Laboratory Services Market?
6. What is the market share of the leading vendors in the United States Next Generation Sequencing CLIA Laboratory Services Market?
7. What modes and strategic moves are considered suitable for entering the United States Next Generation Sequencing CLIA Laboratory Services Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased focus of U.S. government to improve disease screening and monitoring capabilities
5.1.1.2. Rising research and investments in cancer research
5.1.2. Restraints
5.1.2.1. Shortage of skilled professionals in diagnostic centers
5.1.3. Opportunities
5.1.3.1. Technological advances in next generation sequencing technologies
5.1.4. Challenges
5.1.4.1. Computational complications in technology
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Next Generation Sequencing CLIA Laboratory Services Market, by Technology
6.1. Introduction
6.2. Cell Free DNA Sequencing
6.3. Metagenomic Sequencing
6.4. NGS Gene Panel Sequencing
6.5. Targeted Sequencing & Re-sequencing
6.6. Whole Exome Sequencing
6.7. Whole Genome Sequencing

7. Next Generation Sequencing CLIA Laboratory Services Market, by Certificate Types
7.1. Introduction
7.2. Certificate for Provider-Performed Microscopy Procedures
7.3. Certificate of Accreditation
7.4. Certificate of Compliance
7.5. Certificate of Registration
7.6. Certificate of Waiver

8. Next Generation Sequencing CLIA Laboratory Services Market, by Application
8.1. Introduction
8.2. Biomarker Discovery
8.3. Diagnostics
8.4. Drug Discovery
8.5. Precision Medicine

9. Next Generation Sequencing CLIA Laboratory Services Market, by End-users
9.1. Introduction
9.2. Diagnostic Centers
9.3. Hospitals

10. California Next Generation Sequencing CLIA Laboratory Services Market
10.1. Introduction

11. Florida Next Generation Sequencing CLIA Laboratory Services Market
11.1. Introduction

12. Illinois Next Generation Sequencing CLIA Laboratory Services Market
12.1. Introduction

13. New York Next Generation Sequencing CLIA Laboratory Services Market
13.1. Introduction

14. Ohio Next Generation Sequencing CLIA Laboratory Services Market
14.1. Introduction

15. Pennsylvania Next Generation Sequencing CLIA Laboratory Services Market
15.1. Introduction

16. Texas Next Generation Sequencing CLIA Laboratory Services Market
16.1. Introduction

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis, By Key Player
17.3. Market Share Analysis, By Key Player
17.4. Product Portfolio Analysis, By Key Player
17.5. Competitive Scenario
17.5.1. Merger & Acquisition
17.5.2. Agreement, Collaboration, & Partnership
17.5.3. New Product Launch & Enhancement
17.5.4. Investment & Funding
17.5.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. Agilent Technologies, Inc.
18.2. Azenta Life Sciences
18.3. Beijing Genomics Co. Ltd.
18.4. Bio-Rad Laboratories, Inc.
18.5. BioMerieux S.A.
18.6. Charles River Laboratories, Inc.
18.7. Eurofins Scientific SE
18.8. F. Hoffmann-La Roche AG
18.9. Illumina, Inc.
18.10. Macrogen, Inc.
18.11. NanoString Technologies, Inc.
18.12. Perkin Elmer, Inc.
18.13. PierianDx, Inc.
18.14. Pillar Biosciences, Inc.
18.15. Qiagen N.V.
18.16. Saphetor SA
18.17. Takara Bio Inc.
18.18. Thermo Fisher Scientific, Inc.

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET DYNAMICS
FIGURE 8. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY TECHNOLOGY, 2030
FIGURE 12. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CELL FREE DNA SEQUENCING, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY METAGENOMIC SEQUENCING, 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY NGS GENE PANEL SEQUENCING, 2018-2030 (USD MILLION)
FIGURE 15. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TARGETED SEQUENCING & RE-SEQUENCING, 2018-2030 (USD MILLION)
FIGURE 16. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY WHOLE EXOME SEQUENCING, 2018-2030 (USD MILLION)
FIGURE 17. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2018-2030 (USD MILLION)
FIGURE 18. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2022 VS 2030 (%)
FIGURE 19. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY CERTIFICATE TYPES, 2030
FIGURE 21. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE FOR PROVIDER-PERFORMED MICROSCOPY PROCEDURES, 2018-2030 (USD MILLION)
FIGURE 22. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF ACCREDITATION, 2018-2030 (USD MILLION)
FIGURE 23. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF COMPLIANCE, 2018-2030 (USD MILLION)
FIGURE 24. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF REGISTRATION, 2018-2030 (USD MILLION)
FIGURE 25. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF WAIVER, 2018-2030 (USD MILLION)
FIGURE 26. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 27. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 28. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 29. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
FIGURE 30. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
FIGURE 31. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
FIGURE 32. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY PRECISION MEDICINE, 2018-2030 (USD MILLION)
FIGURE 33. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2022 VS 2030 (%)
FIGURE 34. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 35. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USERS, 2030
FIGURE 36. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
FIGURE 37. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
FIGURE 38. CALIFORNIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 39. FLORIDA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 40. ILLINOIS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 41. NEW YORK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 42. OHIO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 43. PENNSYLVANIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 44. TEXAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 45. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 46. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 47. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CELL FREE DNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CELL FREE DNA SEQUENCING, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY METAGENOMIC SEQUENCING, 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY METAGENOMIC SEQUENCING, BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY NGS GENE PANEL SEQUENCING, 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY NGS GENE PANEL SEQUENCING, BY STATE, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TARGETED SEQUENCING & RE-SEQUENCING, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TARGETED SEQUENCING & RE-SEQUENCING, BY STATE, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY WHOLE EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY STATE, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY STATE, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE FOR PROVIDER-PERFORMED MICROSCOPY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE FOR PROVIDER-PERFORMED MICROSCOPY PROCEDURES, BY STATE, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF ACCREDITATION, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF ACCREDITATION, BY STATE, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF COMPLIANCE, BY STATE, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF REGISTRATION, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF REGISTRATION, BY STATE, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF WAIVER, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF WAIVER, BY STATE, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, BY STATE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY DIAGNOSTICS, BY STATE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY STATE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY PRECISION MEDICINE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY PRECISION MEDICINE, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY HOSPITALS, BY STATE, 2018-2030 (USD MILLION)
TABLE 43. CALIFORNIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 44. CALIFORNIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 45. CALIFORNIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 46. CALIFORNIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. CALIFORNIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 48. FLORIDA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 49. FLORIDA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. FLORIDA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 51. FLORIDA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. FLORIDA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 53. ILLINOIS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 54. ILLINOIS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. ILLINOIS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 56. ILLINOIS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. ILLINOIS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 58. NEW YORK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 59. NEW YORK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. NEW YORK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 61. NEW YORK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. NEW YORK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 63. OHIO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 64. OHIO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 65. OHIO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 66. OHIO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. OHIO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 68. PENNSYLVANIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 69. PENNSYLVANIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. PENNSYLVANIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 71. PENNSYLVANIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. PENNSYLVANIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 73. TEXAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 74. TEXAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. TEXAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 76. TEXAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. TEXAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 79. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 80. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 81. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET RANKING, BY KEY PLAYER, 2022
TABLE 82. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SHARE, BY KEY PLAYER, 2022
TABLE 83. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 84. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET MERGER & ACQUISITION
TABLE 85. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 86. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 87. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET INVESTMENT & FUNDING
TABLE 88. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 89. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET: LICENSE & PRICING

Companies Mentioned

  • Agilent Technologies, Inc.
  • Azenta Life Sciences
  • Beijing Genomics Co. Ltd.
  • Bio-Rad Laboratories, Inc.
  • BioMerieux S.A.
  • Charles River Laboratories, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Macrogen, Inc.
  • NanoString Technologies, Inc.
  • Perkin Elmer, Inc.
  • PierianDx, Inc.
  • Pillar Biosciences, Inc.
  • Qiagen N.V.
  • Saphetor SA
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...